The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, GoI, in association with the Ministry of Commerce and Industry, GoI; Export Promotion Council for Medical Devices (EPCMD), and Central Drugs Standard Control Organisation
Novo Nordisk and Apollo Clinics have signed a strategic partnership to provide a comprehensive obesity control program in multiple Indian cities
Sai Life Sciences, a Contract Research, Development, and Manufacturing Organization (CRDMO) focused on innovation, has announced the successful completion of Phase II of its new Production Block (PB-11) at the company’s primary API manufacturing
The plan to combine these separately listed businesses under the Dr. Agarwal's Group has been accepted by the boards of directors of Dr. Agarwal's Health Care Limited (AHCL) and Dr. Agarwal's Eye Hospital Limited (AEHL).
Bristol Myers Squibb presented major clinical and real-world results of its cardiovascular line at the European Society of Cardiology (ESC) Congress, which took place between August 29 and September 1, 2025, in Madrid, Spain. New data on Camzyos (mav
The second chapter of Garmin India's strategic partnership with Apollo HealthAxis, a division of Apollo Hospitals, aims to enhance chronic illness management, health monitoring, and general wellbeing across India. The partnership has entered a new
If not properly handled, shifting GST rates for medical equipment could affect domestic competitiveness, the Association of Indian medical Device Industry (AiMeD) said. The majority of devices are now subject to 12% GST, whilst inputs are subject to
The largest consumer electronics company in India, Samsung, has announced the arrival of its next-generation mobile CT product line in India in partnership with NeuroLogica, a division of Samsung Electronics Co., Ltd.
Dr. Reddy's Laboratories Ltd. has marked a milestone in the Indian pharmaceutical industry, putting forth Linaclotide, the new first-in-class Guanylate Cyclase-C (GC-C) agonist, in adults with chronic constipation. Under the brand name Colozo, the dr
In an interaction with India Pharma Outlook, Deepak Ghagare, Associate Director SBS, Spectrum Pharmatech shares insights on India’s evolving HPAPI manufacturing landscape, emphasizing advanced containment strategies and regulatory alignment.